Mark S Cragg

44PUBLICATIONS
189CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityTumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jul 17, 2026
Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

|Jun 29, 2026
Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilities.

|May 19, 2026
Realizing the potential of agonistic antibody immunotherapy.

|Apr 17, 2026
The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell death.

|Jan 13, 2026
CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.

Lara V Graham, Russell B Foxall, Margaret Ashton-Key

|Dec 20, 2025
Harnessing multivalency and FcγRIIB engagement to augment anti-CD27 immunotherapy.

Marcus A Widdess, Anastasia Pakidi, Hannah J Metcalfe

Pageof 8

Frequent Collaborators

8 joint publications

Stephen A Beers

7 joint publications

Sean H Lim

5 joint publications

Robert J Oldham

4 joint publications

Francesco Forconi